Carmelo Fidone

Improving survival with deferiprone treatment in patients with thalassemia major: A prospective multicenter randomised clinical trial under the auspices of the Italian Society for Thalassemia and Hemoglobinopathies

Aurelio Maggio, Angela Vitrano, Marcello Capra et al. · Blood Cells Molecules and Diseases · 2009 · 96 citations

Hematology, Clinical Trials, Italian Society +5

Hepatocellular carcinoma in thalassaemia: an update of the Italian Registry

Caterina Borgna‐Pignatti, Maria Chiara Garani, Gian Luca Forni et al. · British Journal of Haematology · 2014 · 82 citations · Full text

Long‐term sequential deferiprone–deferoxamine <i>versus</i> deferiprone alone for thalassaemia major patients: a randomized clinical trial

Aurelio Maggio, Angela Vitrano, Marcello Capra et al. · British Journal of Haematology · 2009 · 69 citations

Drug Safety, Therapeutic Drug Monitoring, Randomized Clinical Trial +11

The era of comparable life expectancy between thalassaemia major and intermedia: Is it time to revisit the major‐intermedia dichotomy?

Angela Vitrano, Giuseppina Calvaruso, Eliana Lai et al. · British Journal of Haematology · 2016 · 56 citations · Full text

Heart Failure, Iron Metabolism, Prognosis +19

Real-life experience with hydroxyurea in sickle cell disease: A multicenter study in a cohort of patients with heterogeneous descent

Paolo Rigano, Lucia De Franceschi, Laura Sainati et al. · Blood Cells Molecules and Diseases · 2017 · 55 citations · Full text

Translational Medicine, Sickle Cell Disease, Hematology +4